Glaukos Corp GKOS:NYSE

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 05/17/24 EDT
109.79UNCH (UNCH)
Volume
16,636,727
Close
109.79quote price arrow down-0.62 (-0.56%)
Volume
463,824
52 week range
54.38 - 113.97
Loading...
  • Open110.84
  • Day High110.84
  • Day Low107.41
  • Prev Close110.41
  • 52 Week High113.97
  • 52 Week High Date05/15/24
  • 52 Week Low54.38
  • 52 Week Low Date05/30/23

Key Stats

  • Market Cap5.53B
  • Shares Out50.37M
  • 10 Day Average Volume0.00M
  • Dividend-
  • Dividend Yield-
  • Beta1.09
  • YTD % Change38.12

KEY STATS

  • Open110.84
  • Day High110.84
  • Day Low107.41
  • Prev Close110.41
  • 52 Week High113.97
  • 52 Week High Date05/15/24
  • 52 Week Low54.38
  • 52 Week Low Date05/30/23
  • Market Cap5.53B
  • Shares Out50.37M
  • 10 Day Average Volume0.00M
  • Dividend-
  • Dividend Yield-
  • Beta1.09
  • YTD % Change38.12

RATIOS/PROFITABILITY

  • EPS (TTM)-2.88
  • P/E (TTM)-38.11
  • Fwd P/E (NTM)-52.48
  • EBITDA (TTM)-83.783M
  • ROE (TTM)-29.37%
  • Revenue (TTM)326.434M
  • Gross Margin (TTM)76.18%
  • Net Margin (TTM)-43.16%
  • Debt To Equity (MRQ)78.41%

EVENTS

  • Earnings Date07/31/2024(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Glaukos Corp

 

Profile

MORE
Glaukos Corporation is an ophthalmic pharmaceutical and medical technology company. It develops novel, dropless therapies and commercializing associated products for the treatment of glaucoma, corneal disorders and retinal disease. Its product candidates include Micro-Invasive Glaucoma Surgery products that involve the insertion of a micro-scale device designed to reduce intraocular pressure (IOP) by restoring the natural aqueous humor outflow pathways for patients suffering...
Thomas Burns
Chairman of the Board, Chief Executive Officer
Joseph Gilliam
President, Chief Operating Officer
Alex Thurman
Chief Financial Officer, Senior Vice President
Address
1 GLAUKOS WAY
Aliso Viejo, CA
92656
United States

Top Peers

SYMBOLLASTCHG%CHG
TMDX
Transmedics Group Inc
137.98+3.05+2.26%
INSP
Inspire Medical Systems Inc
155.22-3.81-2.40%
AXNX
Axonics Inc
67.55-0.12-0.18%
PRCT
Procept Biorobotics Corp
68.10-0.04-0.06%
IRTC
iRhythm Technologies Inc
94.83-3.87-3.92%